Published in Am J Med Genet A on June 01, 2006
QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res (2007) 10.08
Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. Ann Neurol (2010) 1.48
Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays. Hum Mol Genet (2013) 1.44
Cortical dysplasia and skull defects in mice with a Foxc1 allele reveal the role of meningeal differentiation in regulating cortical development. Proc Natl Acad Sci U S A (2007) 1.39
Novel retrotransposed imprinted locus identified at human 6p25. Nucleic Acids Res (2011) 0.90
Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p. Genes Brain Behav (2009) 0.88
Molecular analysis of FOXC1 in subjects presenting with severe developmental eye anomalies. Mol Vis (2009) 0.81
A complex 6p25 rearrangement in a child with multiple epiphyseal dysplasia. Am J Med Genet A (2010) 0.80
Haploinsufficiency and triploinsensitivity of the same 6p25.1p24.3 region in a family. BMC Med Genomics (2015) 0.76
Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A (2005) 3.13
Delayed detection of psychosis: causes, consequences, and effect on public health. Am J Psychiatry (2000) 1.98
Delineation of two distinct 6p deletion syndromes. Hum Genet (1999) 1.59
Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry (2002) 1.56
Schizophrenia and mental handicap: an historical review, with implications for further research. Psychol Med (1989) 1.36
Chromosomal abnormalities and schizophrenia. Am J Med Genet (2000) 1.36
Refined genotype-phenotype correlations in cases of chromosome 6p deletion syndromes. Eur J Hum Genet (2004) 1.31
An interstitial deletion of 6p24-p25 proximal to the FKHL7 locus and including AP-2alpha that affects anterior eye chamber development. J Med Genet (1999) 1.29
Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet (2005) 1.24
Genetic insights into the neurodevelopmental hypothesis of schizophrenia. Schizophr Bull (2001) 1.23
Partial deletion of chromosome 6p: delineation of the syndrome. Am J Med Genet (1991) 1.22
Distal 6p deletion syndrome: a report of a case with anterior chamber eye anomaly and review of published reports. J Med Genet (1998) 1.16
Schizophrenia: a genetic disorder of the synapse? BMJ (2005) 1.14
Axenfeld-Rieger malformation and distinctive facial features: Clues to a recognizable 6p25 microdeletion syndrome. Am J Med Genet A (2005) 1.13
Subtelomeric 6p deletion: clinical, FISH, and array CGH characterization of two cases. Am J Med Genet A (2005) 1.12
Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screen. Proc Natl Acad Sci U S A (2005) 1.07
Patterns of dysmorphic features in schizophrenia. Am J Med Genet (2001) 1.03
Two rare cases of 6p partial deletion. Clin Genet (1989) 0.95
Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science (2000) 4.42
Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci (2000) 3.50
LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry (2007) 3.49
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet (1999) 1.96
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer (2011) 1.77
Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. Hum Mol Genet (1995) 1.75
Delineation of two distinct 6p deletion syndromes. Hum Genet (1999) 1.59
Phenotype of adults with the 22q11 deletion syndrome: A review. Am J Med Genet (1999) 1.52
Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer (1993) 1.49
Eye tracking dysfunction is associated with partial trisomy of chromosome 5 and schizophrenia. Arch Gen Psychiatry (1988) 1.43
Premature death in adults with 22q11.2 deletion syndrome. J Med Genet (2009) 1.42
Genetic counselling for schizophrenia in the era of molecular genetics. Can J Psychiatry (2001) 1.41
Map of the human MHC. Immunol Today (1991) 1.36
Velo-cardio-facial syndrome and psychotic disorders: implications for psychiatric genetics. Am J Med Genet (1994) 1.32
An interstitial deletion of 6p24-p25 proximal to the FKHL7 locus and including AP-2alpha that affects anterior eye chamber development. J Med Genet (1999) 1.29
Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am J Hum Genet (1997) 1.29
Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry (1999) 1.23
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. Br J Cancer (2013) 1.21
Neuropathologic features in adults with 22q11.2 deletion syndrome. Cereb Cortex (2008) 1.19
Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry (2001) 1.13
Further evidence for the involvement of human chromosome 6p24 in the aetiology of orofacial clefting. J Med Genet (1998) 1.10
Deletion mapping of DNA markers to a region of chromosome 5 that cosegregates with schizophrenia. Genomics (1989) 1.09
Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene (2015) 1.08
Mapping of three translocation breakpoints associated with orofacial clefting within 6p24 and identification of new transcripts within the region. Cytogenet Genome Res (2004) 1.06
New vector for transfer of yeast artificial chromosomes to mammalian cells. Somat Cell Mol Genet (1993) 1.03
Patterns of dysmorphic features in schizophrenia. Am J Med Genet (2001) 1.03
An oncogenic role of eIF3e/INT6 in human breast cancer. Oncogene (2010) 1.01
Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. J Intellect Disabil Res (2011) 1.01
A detailed investigation of two cases exhibiting characteristics of the 6p deletion syndrome. Hum Genet (1996) 1.00
The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up. Arch Gen Psychiatry (1997) 0.99
Darier's disease: current understanding of pathogenesis and future role of genetic studies. Int J Dermatol (1993) 0.96
The New York High-Risk Project. Psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up. Arch Gen Psychiatry (1995) 0.94
Mapping of HLA genes using pulsed-field gradient electrophoresis. FEBS Lett (1986) 0.93
Transcriptional signature of human adipose tissue-derived stem cells (hASCs) preconditioned for chondrogenesis in hypoxic conditions. Exp Cell Res (2009) 0.91
Molecular cloning, chromosomal mapping, and developmental expression of a novel protein tyrosine phosphatase-like gene. Genomics (1999) 0.91
Search for unstable DNA in schizophrenia families with evidence for genetic anticipation. Am J Hum Genet (1996) 0.89
Temporal lobe abnormalities in multigenerational families with schizophrenia. Biol Psychiatry (1994) 0.89
A posterior probability of linkage-based re-analysis of schizophrenia data yields evidence of linkage to chromosomes 1 and 17. Hum Hered (2006) 0.88
NCAM and schizophrenia: genetic studies. Mol Psychiatry (1997) 0.88
No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families. Am J Med Genet (1998) 0.88
Elevated rates of schizophrenia in a familial sample with mental illness and intellectual disability. J Intellect Disabil Res (2004) 0.87
Familial 5q11.2----q13.3 segmental duplication cosegregating with multiple anomalies, including schizophrenia. Am J Med Genet (1990) 0.87
Postmaturity in a genetic subtype of schizophrenia. Acta Psychiatr Scand (2003) 0.87
Isolation and characterization of human and mouse ZIRTL, a member of the IRT1 family of transporters, mapping within the epidermal differentiation complex. Genomics (1999) 0.87
Fine mapping of the human MHC class II region within chromosome band 6p21 and evaluation of probe ordering using interphase fluorescence in situ hybridization. Cytogenet Cell Genet (1993) 0.87
Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps. J Invest Dermatol (1999) 0.87
Absence of linkage for schizophrenia on the short arm of chromosome 5 in multiplex Canadian families. Am J Med Genet (1997) 0.86
Assignment of the TCP1 locus to the long arm of human chromosome 6 by in situ hybridization. Cytogenet Cell Genet (1987) 0.86
New polymorphism for the human serotonin 1D receptor variant (5-HT1D beta) not linked to schizophrenia in five Canadian pedigrees. Hum Hered (1993) 0.86
An integrated map of human chromosome 6p23. Genome Res (1995) 0.86
Low platelet count in a 22q11 deletion syndrome subtype of schizophrenia. Schizophr Res (2001) 0.85
Recent advances in the genetics of schizophrenia. Cell Mol Life Sci (2002) 0.85
Construction of a high-resolution 2.5-Mb transcript map of the human 6p21.2-6p21.3 region immediately centromeric of the major histocompatibility complex. Genome Res (2000) 0.84
Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study. Schizophr Res (2007) 0.84
Bioavailabiltity and side effects of different lithium carbonate products. Neuropsychobiology (1976) 0.84
High-resolution YAC fragmentation map of 1q21. Genomics (1998) 0.83
Characterization and mapping of the human SOX4 gene. Mamm Genome (1993) 0.82
A genotype-phenotype research strategy for schizophrenia. Can J Psychiatry (1990) 0.82
A case study of temporal lobe development in familial schizophrenia. Psychol Med (1996) 0.82
The temporal lobes, reversed asymmetry and the genetics of schizophrenia. Neuroreport (1995) 0.82
Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44. Mol Psychiatry (2005) 0.82
Association of the androgen receptor CAG repeat polymorphism with Alzheimer's disease in men. Neurosci Lett (2003) 0.81
Linkage analysis between schizophrenia and the Darier's disease region on 12q. Psychiatr Genet (1996) 0.81
The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43. Clin Genet (2012) 0.81
Paternal transmission and anticipation in schizophrenia. Am J Med Genet (1998) 0.81
Detection, breakpoint identification and detailed characterisation of a CNV at the FRA16D site using SNP assays. Cytogenet Genome Res (2009) 0.81
A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes. Mol Pharmacol (1998) 0.80
A comprehensive method of assessing routine CT scans in schizophrenia. Acta Psychiatr Scand (1997) 0.80
Partial trisomy 22 in a liveborn resulting from a rearrangement between chromosomes 6 and 22. J Med Genet (2000) 0.80
Genetic linkage evaluation of twenty-four loci in an eastern Canadian family segregating Darier's disease (keratosis follicularis). J Am Acad Dermatol (1994) 0.79
Genetic linkage for Darier disease (keratosis follicularis). Am J Med Genet (1995) 0.79
A serpin gene cluster on human chromosome 6p25 contains PI6, PI9 and ELANH2 which have a common structure almost identical to the 18q21 ovalbumin serpin genes. Cytogenet Cell Genet (1998) 0.79
cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects. Pharmacogenomics J (2006) 0.79
Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment. Pharmacogenomics J (2004) 0.78
Organization of the human HLA-class-II region. Int J Cancer Suppl (1991) 0.78
The androgen receptor CAG repeat and serum testosterone in the risk of Alzheimer's disease in men. J Neurol Neurosurg Psychiatry (2004) 0.78
Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome. J Intellect Disabil Res (2012) 0.78
Progress on the genetics of schizophrenia. J Psychiatry Neurosci (1998) 0.78
Physical map of human 6p21.2-6p21.3: region flanking the centromeric end of the major histocompatibility complex. Genome Res (1998) 0.77
The minisatellite of the GPI/AMF/NLK/MF gene: interspecies conservation and transcriptional activity. Gene (2001) 0.77
Dermatoglyphic profile in 22q deletion syndrome. Am J Med Genet B Neuropsychiatr Genet (2004) 0.76
Fine mapping of 39 ESTs on human chromosome 6p23-p25. Genomics (1997) 0.76
Molecularly defined interstitial tandem duplication 6p case with mild manifestations. Am J Med Genet (2001) 0.76